CE2 - COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY VERSUS A DUAL INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
Abstract
Authors
N. Benjamin A. Huerta C. Biswas M. Schroeder J. Whalen Alonso J.L. Izquierdo J.J. Soler Cataluña J.A. Riesco Miranda A. Martin L. Atienza A. Ismaila